• Home
  • Editorial Board
  • Articles
    • Editorials
    • Guest Articles
  • News
    • Featured
    • Biotech News
  • Interviews
    • Interviews – Academia
    • Interviews – Industry
  • Issues – Archives
  • Subscribe
  • Contact
Facebook Twitter Instagram
Trending
  • CDC Boss kicked out in RFK Jr.’s War on Corruption in pharma and healthcare
  • Prof. Rajeev Varshney FRS, now joins Australian Academy of Science
  • Dr. Cyrus S. Poonawalla, SII unveiled the newly built School for Hearing Impaired in Pune
  • AdFalciVax: ICMR’s New Malaria Vaccine: Hope or Premature Hype?”
  • The Sudden Deaths and COVID Vaccines: A Critical Analysis of the ICMR and AIIMS Studies
  • KGMU Scandal: Dr. Tulika Chandra Exposed in Crore Rupee Forgery and Scam
  • Zydus to launch market-specific dosage variants of Semaglutide, MD says
  • Biocon Biologics Launches Nepexto, Etanercept Biosimilar in Australia
Saturday, October 11
Facebook Twitter Instagram LinkedIn
Biotech Express
  • Home
  • Editorial Board
  • Articles
    • Editorials
    • Guest Articles
  • News
    • Featured
    • Biotech News
  • Interviews
    1. Interviews – Academia
    2. Interviews – Industry
    Featured
    04/01/20241

    Interview: Reach to common man is the heart and soul of India International Science Festival- Dr. Arvind C Ranade Chief Coordinator, IISF- 2023

    Recent
    04/01/2024

    Interview: Reach to common man is the heart and soul of India International Science Festival- Dr. Arvind C Ranade Chief Coordinator, IISF- 2023

    22/05/2023

    Prof Rajeev Varshney becomes the 4th Indian Agricultural Scientist to be elected as Fellow of the Royal Society

    26/07/2022

    We are making best hygiene solutions through Biotech applications: Dr Rachna Dave, founder MicroGO

  • Issues – Archives
  • Subscribe
  • Contact
Biotech Express
You are at:Home»Biotech News»First-of-its-kind cryoablation procedure carried out in India at Max Hospital

First-of-its-kind cryoablation procedure carried out in India at Max Hospital

0
By Biotech Express on 22/04/2022 Biotech News

A first-of-its-kind therapy in India, a cryoablation procedure using specialized balloon catheter systems was recently done on a patient with atrial fibrillation by Dr Balbir Singh and his team at Max Hospital Saket.

The procedure was done using cold energy to create tiny scars in the heart to block irregular electrical signals and restore a regular heartbeat. Cryoablation was chosen over as a safe, effective, and efficient treatment option since it could be completed in record time leading to least possible exposure to radiation for the patient. There is a need to raise awareness on the availability of this therapy in India.

A case in point is that of a patient who presented with palpitations and fatigue despite being on multiple medications. The underlying heart rhythm was regular which is typical of any patient unsuccessfully managed with one or multiple drugs leading to a medical condition called drug resistant paroxysmal atrial fibrillation. However, his diagnosis was paroxysmal Atrial Fibrillation, and the patient was willing to get this treatment as his quality of life was compromised and he wanted an improvement in the same.

Cryoablation, a proven modality was clearly the treatment of choice. This is because it could be performed within a significantly shorter duration (as opposed to Radio frequency ablation) with safer protocols and equally efficient outcomes.

Speaking about this, Dr Balbir Singh, Chairman, Cardiology at Max Hospital Saket, New Delhi, said, “Whether your symptoms are mild or severe, atrial fibrillation can be a serious medical condition that should be treated. It may impact your quality of life, energy level, and physical activity. If left untreated, atrial fibrillation may increase the risk of heart failure, stroke, and death. Some symptoms to watch out for include irregular heartbeat which is rapid and fluttering in nature; fatigue, shortness of breath and weakness; chest discomfort or pain; and dizziness.

Cryoablation is a novel procedure, which is short, highly safe and effective for people with atrial fibrillation. This modality can revolutionize the treatment of this condition in India, and we are extremely proud to say that the first case in the country has been successfully carried out by our team at Max Hospital, Saket.”

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
Biotech Express
  • Website
  • Facebook
  • Twitter
  • LinkedIn

ISSN: 2454-6968 | Biotech Express Magazine publishes articles in the field of biotechnology and allied sciences in a way that have never been presented earlier. It publishes Editorials, Guest Articles, Reports, Interviews, Current News of Govt. Academics and Business, Research Highlights and Notifications of Events, Jobs, Research Proposals in the field of Biotechnology, Biological Sciences, Life Sciences, Microbiology, Biochemistry, Neurosciences, Genetics, Medical Sciences, BioPharma etc.

Related Posts

AdFalciVax: ICMR’s New Malaria Vaccine: Hope or Premature Hype?”

KGMU Scandal: Dr. Tulika Chandra Exposed in Crore Rupee Forgery and Scam

Zydus to launch market-specific dosage variants of Semaglutide, MD says

Leave A Reply Cancel Reply

Current Issue – September 2025
Biotech Express – e-ISSN: 2454-6968

Editorial Board

For Authors – Article Submission and Guidelines

Peer Review Policies

License and Copyright

Advertisement

Recent Posts
  • CDC Boss kicked out in RFK Jr.’s War on Corruption in pharma and healthcare 21/09/2025
  • Prof. Rajeev Varshney FRS, now joins Australian Academy of Science 20/09/2025
  • Dr. Cyrus S. Poonawalla, SII unveiled the newly built School for Hearing Impaired in Pune 19/09/2025
  • AdFalciVax: ICMR’s New Malaria Vaccine: Hope or Premature Hype?” 18/09/2025
  • The Sudden Deaths and COVID Vaccines: A Critical Analysis of the ICMR and AIIMS Studies 17/09/2025
  • KGMU Scandal: Dr. Tulika Chandra Exposed in Crore Rupee Forgery and Scam 16/09/2025
  • Zydus to launch market-specific dosage variants of Semaglutide, MD says 15/09/2025
  • Biocon Biologics Launches Nepexto, Etanercept Biosimilar in Australia 15/09/2025
  • India launched its first National Biofoundry Network 15/09/2025
  • India has 94 Biotech Incubators across 25 states over 13 years 15/09/2025
Archives
Categories
  • Articles
  • Biotech News
  • Controversial
  • Editorials
  • Events
  • Featured
  • Guest Articles
  • Interviews
  • Interviews – Academia
  • Interviews – Industry
  • News-Industry
  • News-Research
  • Policies
  • SARS- CoV2 & COVID-19 Updates
  • Start-ups
About Us

About Biotech Express

Advisory and Editorial Board

Contact Us

Submission Policy and Guidelines

Submission policies

 

 

Follow us on Social Media
  • Facebook
  • Twitter
  • YouTube
We use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of cookies. Copyright © 2013-2025 Biotech Express except certain content provided by third parties.

Type above and press Enter to search. Press Esc to cancel.